“Saving children’s lives" - GAVI Alliance pledging conference
MAY 2011 | GENEVA
A pledging conference entitled “Saving children’s lives” for GAVI Alliance partners, GAVI donors, co-financing countries and vaccine manufacturers will assemble on 13 June 2011 in London United Kingdom to address the need to raise US$ 3.7 billion to scale-up immunisation programmes between 2011 and 2015 with the aim of saving four million lives. Additionally, the Alliance’s Civil Society Organization Constituency has come together to call on donors to fully fund the Alliance’s new strategy.
Below, read the full press release from the GAVI Alliance. On the right, link to the GAVI Alliance website with full details of the Pledging conference, GAVI Alliance 2010 Decade Report, and the GAVI Alliance CSO Constituency Call to Action.
New vaccines offer the opportunity to give children a healthy start in life. Despite significant progress made in reducing childhood mortality, nearly two million children die each year from vaccine-preventable diseases. Most of these deaths occur in low-income countries. Pneumonia and diarrhoea are the two leading killers, causing nearly 40% of all childhood deaths.
The world’s poorest countries have expressed a strong interest in introducing new and underused vaccines. To date, 45 GAVI-eligible countries have expressed an interest in offering a vaccine against pneumococcal disease and 33 GAVI-eligible countries are planning to introduce a rotavirus vaccine against diarrhoeal disease.
Responding to this demand for vaccines, the GAVI Alliance and its partners can seize the opportunity to save an additional four million children’s lives by rolling out new vaccines to tackle the main killers of children, pneumonia and diarrhoea. If fully funded, GAVI will support advances towards making a significant contribution to reducing under-five mortality, Millennium Development Goal 4, and to achieve the goals of the G8 leaders Muskoka Initiative to improve maternal, new born and child health.
Full GAVI funding would also enable the Alliance to immunise an additional 243 million children in the poorest countries with vaccines against pneumococcal disease, rotavirus, Haemophilus influenzae type b (Hib), hepatitis B, and yellow fever, and ensure the complete roll-out of pentavalent vaccine. GAVI also aims to introduce new vaccines against human papillomavirus (HPV), which causes cervical cancer in women, meningitis serogroup A, rubella, typhoid and Japanese encephalitis. In addition to its vaccine portfolio, GAVI provides support to country health systems to effectively deliver immunization.
GAVI funding required to meet this challenge
GAVI seeks to meet a rise in country demand for new and underused vaccines, in particular against pneumococcal disease. This requires funding of US$ 6.8 billion from 2011 to 2015. Ninety percent will go directly to vaccine support and associated services. US$ 3.1 billion of that amount is already assured through donor contributions and other sources. GAVI seeks pledges of US$3.7 billion in total to fully address this demand, including US$1.7 billion between 2011 and 2013.
GAVI support to developing countries will be significantly enhanced if this funding is provided as more predictable long-term funding, critical to multi-year immunisation programmes, rather than annual, ad hoc contributions. Donors are also encouraged to donate to the innovative funding mechanisms, including IFFIm.
The evidence base: more than five million lives saved in GAVI’s first decade
GAVI has proven that it can achieve these results. Thanks to strong donor support, the GAVI Alliance has committed US$4 billion to country-led initiatives in the world’s poorest regions over the last decade. This enabled the Alliance to reach 288 million children with vaccines and save more than five million lives in its first decade of operations.
Investments in immunisation are among the best value for money in global health. Immunisation is a highly-cost-effective foundation for strong communities and economies. For every premature death averted as a result of childhood immunisation, millions more are protected from common but preventable diseases enabling them to lead healthy and productive lives.
Millennium Development Goals and the Muskoka Initiative
With the funding in place, GAVI estimates it can save an additional four million lives in developing countries thereby making a significant contribution to reducing under-five mortality, Millennium Development Goal 4.
Every dollar invested in GAVI programmes will move the international community closer to achieving the goals of the G8 leaders’ 2010 Muskoka Initiative, designed to improve maternal, new born and child health. The G8 has agreed that funding to GAVI counts 100 percent towards the Muskoka Initiative.
GAVI’s Resource Mobilisation Process
The June 2011 pledging conference follows two meetings in 2010 of GAVI Alliance donors and stakeholders. The GAVI resource mobilisation process 2010-2015 was designed at the High-Level Meeting on Financing Country Demand in The Hague in March 2010, where donors discussed and endorsed the compelling evidence of the cost-effectiveness of immunisation as a means to improve health and achieve the Millennium Development Goals.
The process was formally launched in October 2010 at the GAVI Call for Action and Resources meeting, where some early pledges were made. The resource mobilization efforts will culminate in London at the “Saving children’s lives - the GAVI Alliance pledging conference for immunisation” on 13 June 2011.
Who is saying “what” about GAVI
In the lead-up to “Saving children’s lives - the GAVI Alliance pledging conference for immunisation” to be held on 13 June 2011 in London, the work of the GAVI Alliance and its partners is attracting increasing attention